# ClinicalTrials.gov record NCT04883346

> PeptideScanner retained ClinicalTrials.gov record NCT04883346 at 2026-07-30T18:38:25.517Z. Its registry update date was 2024-11-20, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct04883346-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-11-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04883346-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04883346-liraglutide-v1.json
- Content SHA-256: `75ab38f89311f6040fad6b0fd4c1215f43662af4f3557ea3405fd2d84275dbb9`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04883346 ([`ctg-observation-nct04883346-2024-11-20-67f263748e10`](#source-ctg-observation-nct04883346-2024-11-20-67f263748e10))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04883346 at 2026-07-30T18:38:25.517Z. Its registry update date was 2024-11-20, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct04883346-2024-11-20-67f263748e10`](#source-ctg-observation-nct04883346-2024-11-20-67f263748e10))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04883346 at 2026-07-30T18:38:25.517Z. Its registry update date was 2024-11-20, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct04883346-2024-11-20-67f263748e10`](#source-ctg-observation-nct04883346-2024-11-20-67f263748e10))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04883346-2024-11-20-67f263748e10`](#source-ctg-observation-nct04883346-2024-11-20-67f263748e10))

## Sources

<a id="source-ctg-observation-nct04883346-2024-11-20-67f263748e10"></a>
- **ClinicalTrials.gov record NCT04883346 · retained source version 2024-11-20:67f263748e102c9ec54f5ed3cbce1d91cdcf951e33ce667e4107286d2d470172** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04883346) (`ctg-observation-nct04883346-2024-11-20-67f263748e10`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04883346." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04883346-liraglutide-v1.json SHA-256: 75ab38f89311f6040fad6b0fd4c1215f43662af4f3557ea3405fd2d84275dbb9.